Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma
Titel:
Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma
Auteur:
Locke, Frederick L. Rossi, John M. Neelapu, Sattva S. Jacobson, Caron A. Miklos, David B. Ghobadi, Armin Oluwole, Olalekan O. Reagan, Patrick M. Lekakis, Lazaros J. Lin, Yi Sherman, Marika Better, Marc Go, William Y. Wiezorek, Jeffrey S. Xue, Allen Bot, Adrian